Drugs Made In America Acquisition Corp. - Units (DMAAU) closed at $11.00 on October 27, 2026, down 0.1% from the previous close, on volume of 209 shares (30-day average 161).
Data as of October 27, 2026.
No headlines found.
No press releases found.
No news found.
Drugs Made In America Acquisition Corp. - Units trades on the stock market under the symbol DMAAU.
As of October 29, 2026, DMAAU stock price was flat at $11.00 with 4 million shares trading.
DMAAU has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
DMAAU has underperformed the market in the last year with a return of +5.0%, while the SPY ETF gained +13.0%. In the last 3 month period, DMAAU fell short of the market, returning +0.3%, while SPY returned +4.0%. However, in the most recent 2 weeks DMAAU has outperformed the stock market by returning +0.1%, while SPY returned -0.1%.
DMAAU support price is $10.84 and resistance is $11.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DMAAU shares will trade within this expected range on the day.
